drugset / Trial / NCT02457195

Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting

NCT02457195

Phase 2 Completed 50 enrolled Milton S. Hershey Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The objective of the study is to evaluate the efficacy and safety of adding transdermal preparation of granisetron (Sancuso ®) to the current postoperative nausea and vomiting (PONV) standard prophylaxis regimen with dexamethasone and ondansetron in patients with the previous history of severe, particularly delayed and/or post-discharge, PONV and undergoing surgical procedure under general anesthesia. The specific aims of the study include: 1. efficacy of the investigated therapy in prevention of PONV up to 120 hours after surgery 2. incidence and seriousness of the observed side effects 3. ability of patients to self-administer preoperatively and maintain the investigated patch during the perioperative period 4. level of satisfaction with the preoperative PONV prophylaxis.

Timeline

Start
2016-02
Primary completion
2018-02-19
Completion
2018-02-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Granisetron Other / unclassified Other

Indications

No indication recorded.